Coronary disease & ACSCohort study

Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study

Eur J Prev CardiolPublished

  • Retrospective cohort study
  • matched 1:3
  • nationwide

Authors' conclusion

RA was associated with increased MI risk irrespective of seropositivity status.

Study context

Population
Adults aged ≥ 40 years newly diagnosed with RA and matched non-RA controls, Korean National Health Insurance System databasematched 1:3
Participants
36,377 vs 109,131
Exposure
RA vs non-RA controls
  • RAn = 36,377
  • Non-RAn = 109,131reference
Outcome
MI
Follow-up
Mean 5.6 ± 2.3 years

Main finding

As reported in the abstract

Subdistribution hazard ratio

1.84

95% CI 1.67–2.01

Events by group

RA

738

events

Non-RA

1201

events

RA vs Non-RA
sHR 1.84 (95% CI 1.67–2.01)

Observational data: associations, not effects.

Further findings

OutcomeValuessHR (95% CI)
MI by seropositivity — SNRA vs Non-RASNRA 186 events · SPRA 552 events1.74 (1.49–2.04)
MI by seropositivity — SPRA vs Non-RA1.87 (1.69–2.07)
MI by bDMARD use (exploratory) — bDMARD use vs Non-RA · exploratory analysisbDMARD use 64 events2.34 (2.05–2.67)
MI by bDMARD use (exploratory) — No bDMARD use vs Non-RA · exploratory analysis1.81 (1.72–1.91)
MI by tsDMARD use (exploratory) — tsDMARD use vs Non-RA · not significant · exploratory analysistsDMARD use 4 events1.43 (0.90–2.28)
MI by tsDMARD use (exploratory) — No tsDMARD use vs Non-RA · exploratory analysis1.86 (1.77–1.96)

Original publication

Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study. Eur J Prev Cardiol. Published 10 July 2026. doi:10.1093/eurjpc/zwag358

Summarised from the published abstract; every number is checked against it